Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Brammer Bio

Brammer Bio
2006 FOUNDED
PRIVATE STATUS
501-600 EMPLOYEES
M&A LATEST DEAL TYPE (Announced)
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides clinical and commercial development, manufacturing supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with the process and analytical development, and regulatory support, enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.

Formerly Known As
Florida Biologix
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 250 Binney Street
  • Cambridge, MA 02142
  • United States

+1 (866) 000-0000

Brammer Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Brammer Bio‘s full profile, request access.

Request full access to PitchBook

Brammer Bio Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Paragon Bioservices Formerly PE-Backed Baltimore, MD 000 000.00 000000&0 000.00
0000000 Corporation Loures, Portugal
000000000 00000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000 000000000000 Venture Capital-Backed Epalinges, Switzerland 00 00000 00000000000 00000
000 0000000000000 Private Equity-Backed Saint Asaph, United Kingdom 00 000.00 0000000 0000 000.00
To view this company’s complete list of competitors, request access »

Brammer Bio Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 31-Mar-2016 0000000000 Biotechnology 0000000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

Brammer Bio Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Brammer Bio‘s full profile, request access.

Request full access to PitchBook

Brammer Bio Executive Team (6)

Name Title Board
Seat
Contact
Info
Steven Favaloro Chief Financial Officer
Christopher Murphy Chief Operating Officer
Richard Snyder Ph.D Chief Scientific Officer, Board Member & Co-Founder
Steve Falcone Chief Quality Officer
Mark Bamforth President & Chief Executive Officer

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Brammer Bio Board Members (3)

Name Representing Role Since Contact
Info
00000 00000000 00.0 Ampersand Capital Partners Board Member 000 0000
0000000 000000 00.0 Ampersand Capital Partners Board Member 000 0000
00000 0000000 00.0 Brammer Bio Board Member 000 0000